TMCI (Treace Medical Concepts, Inc.) Stock Financials & Earnings

TMCITreace Medical Concepts, Inc.

Mkt Cap$104M

Healthcare·Medical - Devices·🇺🇸 United States·NASDAQ

Revenue (TTM)$213M

Net Income (TTM)-$59M

EPS (TTM)-$0.94

Free Cash Flow (TTM)-$29M

Gross Margin79.8%

Op. Margin-25.5%

Net Margin-27.7%

FCF Margin-13.9%

P/S Ratio (TTM)0.5x

P/E Ratio (TTM)—

YoY Rev Growth+1.6%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$42M	$34M	-$14M
Q2 23	$42M	$34M	-$13M
Q3 23	$41M	$33M	-$18M
Q4 23	$62M	$51M	-$7M
Q1 24	$51M	$41M	-$19M
Q2 24	$44M	$36M	-$21M
Q3 24	$45M	$36M	-$15M
Q4 24	$69M	$55M	-$204K
Q1 25	$53M	$42M	-$16M
Q2 25	$47M	$38M	-$17M
Q3 25	$50M	$40M	-$16M
Q4 25	$63M	$50M	-$6M

Valuation

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q1 23	$3M	$11M	$34M
Q2 23	$4M	$10M	$34M
Q3 23	$4M	$13M	$34M
Q4 23	$4M	$13M	$40M
Q1 24	$5M	$14M	$40M
Q2 24	$5M	$14M	$38M
Q3 24	$5M	$14M	$33M
Q4 24	$5M	$14M	$37M
Q1 25	$6M	$16M	$36M
Q2 25	$5M	$16M	$33M
Q3 25	$5M	$16M	$33M
Q4 25	$5M	$15M	$38M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$30M	$141M	$171M
Q2 23	$12M	$127M	$139M
Q3 23	$7M	$115M	$122M
Q4 23	$13M	$110M	$123M
Q1 24	$9M	$101M	$110M
Q2 24	$18M	$77M	$95M
Q3 24	$12M	$71M	$83M
Q4 24	$11M	$64M	$76M
Q1 25	$13M	$63M	$76M
Q2 25	$8M	$61M	$69M
Q3 25	$8M	$50M	$57M
Q4 25	$11M	$38M	$48M

Shares Outstanding

Revenue Per Employee

Revenue / Employee